Product Details
Sandoz Lisdexamfetamine Capsules
Lisdexamfetamine Dimesylate70 mg
Capsule
DIN/PIN/NPN
02546302
Manufacturer
Sandoz Canada Inc.
Formulary Listing Date
2024-07-31
Unit Price
4.6968
Amount MOH Pays
NA
Coverage Status
Off-Formulary Interchangeable
ODB Formulary Therapeutic Classification
Therapeutic Note
C.N.S. Stimulants (28:20): Stimulant medication should only be used when diagnostic criteria for narcolepsy or attention deficit disorder have been met and when stimulant medication has been demonstrated to produce clinical benefits. The use of conventional-release medication should almost always precede the use of extended-release preparations.
ATC Code
N06BA12
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02546302 | Sandoz Lisdexamfetamine Capsules | 4.6968 | NA |
| 02545942 | Teva Lisdexamfetamine | 4.6968 | NA |
| 02458071 | Vyvanse | NA | NA |
| 02546728 | Apo-Lisdexamfetamine | 4.6968 | NA |